RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. [electronic resource]
- Molecular therapy : the journal of the American Society of Gene Therapy Feb 2010
- 370-6 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1525-0024
10.1038/mt.2009.271 doi
Animals Gene Silencing--physiology HIV Infections--genetics Leukocytes--metabolism Liposomes--therapeutic use Lymphocyte Function-Associated Antigen-1--genetics Mice Nanoparticles--therapeutic use RNA Interference RNA, Small Interfering--genetics Receptors, CCR5--genetics Reverse Transcriptase Polymerase Chain Reaction